Cardlytics, Inc. $CDLX Shares Bought by Quinn Opportunity Partners LLC

Quinn Opportunity Partners LLC raised its stake in Cardlytics, Inc. (NASDAQ:CDLX) by 900.0% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,100,000 shares of the company’s stock after buying an additional 990,000 shares during the quarter. Quinn Opportunity Partners LLC’s holdings in Cardlytics were worth $2,673,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Citizens Financial Group Inc. RI purchased a new position in shares of Cardlytics during the 3rd quarter worth $1,260,000. UBS Group AG grew its holdings in shares of Cardlytics by 112.5% in the third quarter. UBS Group AG now owns 458,066 shares of the company’s stock valued at $1,113,000 after purchasing an additional 242,536 shares during the period. Jane Street Group LLC grew its holdings in shares of Cardlytics by 263.0% in the second quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock valued at $267,000 after purchasing an additional 117,687 shares during the period. Private Advisor Group LLC acquired a new stake in Cardlytics during the third quarter worth about $272,000. Finally, XTX Topco Ltd increased its position in Cardlytics by 143.5% during the second quarter. XTX Topco Ltd now owns 85,971 shares of the company’s stock worth $141,000 after purchasing an additional 50,663 shares during the last quarter. 68.10% of the stock is owned by institutional investors and hedge funds.

Cardlytics Stock Performance

NASDAQ CDLX opened at $0.67 on Friday. The stock has a market cap of $37.14 million, a PE ratio of -0.35 and a beta of 1.03. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 2.87. Cardlytics, Inc. has a twelve month low of $0.66 and a twelve month high of $3.28. The stock has a fifty day simple moving average of $1.00 and a 200-day simple moving average of $1.35.

Cardlytics (NASDAQ:CDLX) last issued its quarterly earnings data on Wednesday, March 4th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.08). The business had revenue of $56.10 million for the quarter, compared to analyst estimates of $54.46 million. Cardlytics had a negative return on equity of 370.98% and a negative net margin of 44.36%. Equities analysts anticipate that Cardlytics, Inc. will post -1.52 earnings per share for the current year.

Insiders Place Their Bets

In other Cardlytics news, CEO Amit Gupta sold 52,049 shares of Cardlytics stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $0.90, for a total transaction of $46,844.10. Following the completion of the sale, the chief executive officer directly owned 704,803 shares in the company, valued at $634,322.70. This trade represents a 6.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold a total of 117,875 shares of company stock worth $113,022 over the last ninety days. Company insiders own 4.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cardlytics in a research note on Monday, December 29th. Evercore set a $1.00 price target on shares of Cardlytics in a research note on Friday, March 6th. Finally, Bank of America restated an “underperform” rating on shares of Cardlytics in a report on Thursday, March 5th. Two analysts have rated the stock with a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average price target of $1.75.

Cardlytics Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.